国际脑血管病杂志
國際腦血管病雜誌
국제뇌혈관병잡지
INTERNATIONAL JOURNAL OF CEREBROVASCULAR DISEASES
2010年
1期
21-25
,共5页
吴永忠%常履华%任惠%王艳
吳永忠%常履華%任惠%王豔
오영충%상리화%임혜%왕염
脑出血%脑梗死%血栓调节蛋白%多态现象,遗传
腦齣血%腦梗死%血栓調節蛋白%多態現象,遺傳
뇌출혈%뇌경사%혈전조절단백%다태현상,유전
Cerebral hemorrhage%Brain infarction%Thrombomodulin%Polymorphism,genetic
目的 探讨急性脑血管病患者血浆可溶性血栓调节蛋白(soluble thrombomodulin,sTM)含量的变化和血栓调节蛋白基因Ala455Val(C1418T)多态性的分布.方法 在79例汉族急性脑血管病患者(脑出血患者30例,脑梗死患者49例)和30名年龄和性别相匹配的健康对照者中,采用聚合酶链反应限制性酶切片段长度多态性分析技术检测TM Ala455Val(C1418T)多态性,酶联免疫吸附试验检测血浆sTM含量.结果 脑梗死组和脑出血组sIM含量分别为(32.08±6.98)ng/ml和(38.93±6.77)ng/ml,显著高于正常对照组的(9.90±3.09)ng/ml(P均<0.01),而且与高血压、糖尿病、心脏病等高危因素无关;脑出血组和脑梗死组TM 1418C/C基因型频率分别为53.3%和57.1%,高于对照组的40%,但无统计学差异.结论 无论足脑出血还是腑梗死患者,血浆sTM含量均显著高于正常人群;汉族人群中脑出血和脑梗死患者TM 1418C/C基因型频率虽然高于正常人群,但并非脑血管病的易感基因.
目的 探討急性腦血管病患者血漿可溶性血栓調節蛋白(soluble thrombomodulin,sTM)含量的變化和血栓調節蛋白基因Ala455Val(C1418T)多態性的分佈.方法 在79例漢族急性腦血管病患者(腦齣血患者30例,腦梗死患者49例)和30名年齡和性彆相匹配的健康對照者中,採用聚閤酶鏈反應限製性酶切片段長度多態性分析技術檢測TM Ala455Val(C1418T)多態性,酶聯免疫吸附試驗檢測血漿sTM含量.結果 腦梗死組和腦齣血組sIM含量分彆為(32.08±6.98)ng/ml和(38.93±6.77)ng/ml,顯著高于正常對照組的(9.90±3.09)ng/ml(P均<0.01),而且與高血壓、糖尿病、心髒病等高危因素無關;腦齣血組和腦梗死組TM 1418C/C基因型頻率分彆為53.3%和57.1%,高于對照組的40%,但無統計學差異.結論 無論足腦齣血還是腑梗死患者,血漿sTM含量均顯著高于正常人群;漢族人群中腦齣血和腦梗死患者TM 1418C/C基因型頻率雖然高于正常人群,但併非腦血管病的易感基因.
목적 탐토급성뇌혈관병환자혈장가용성혈전조절단백(soluble thrombomodulin,sTM)함량적변화화혈전조절단백기인Ala455Val(C1418T)다태성적분포.방법 재79례한족급성뇌혈관병환자(뇌출혈환자30례,뇌경사환자49례)화30명년령화성별상필배적건강대조자중,채용취합매련반응한제성매절편단장도다태성분석기술검측TM Ala455Val(C1418T)다태성,매련면역흡부시험검측혈장sTM함량.결과 뇌경사조화뇌출혈조sIM함량분별위(32.08±6.98)ng/ml화(38.93±6.77)ng/ml,현저고우정상대조조적(9.90±3.09)ng/ml(P균<0.01),이차여고혈압、당뇨병、심장병등고위인소무관;뇌출혈조화뇌경사조TM 1418C/C기인형빈솔분별위53.3%화57.1%,고우대조조적40%,단무통계학차이.결론 무론족뇌출혈환시부경사환자,혈장sTM함량균현저고우정상인군;한족인군중뇌출혈화뇌경사환자TM 1418C/C기인형빈솔수연고우정상인군,단병비뇌혈관병적역감기인.
Objective To investigate the changes of plasma soluble thrombomodulin (sTM) and the distribution of thrombomodulin Ala455Val (C1418T) polymorphism in patients with acute cerebrovascular diseases. Methods Among the 79 Chinese Han patients with acute cerebrovascular disease (30 intracerebral hemorrhage, and 49 cerebral infarction) and 30 age-and sex-matched healthy controls, polymerase chain reaction-restriction fragment length polymor phism (PCR-RFLP) analysis was used to detect TM Ala455Val (C1418T) polymorphism, and enzyme-linked immunosorbent assay (ELISA) was used to detect sTM level. Results The sTM levels in the cerebral infarction and intracerebral hemorrhage groups were 32. 08 ± 6. 98 ng/ml and 38. 93 ±6. 77 ng/ml, respectively. They were significantly higher than 9. 90 ±3. 09 ng/mL in the healthy control group (all P < 0. 01) and were not associated with the high risk factors, such as hypertension, diabetes, and cardiac disease etc; TM 1418C/C genotype frequencies in the intthe intracerebral hemorrhage and cerebral infarction groups were 53. 3% and 57.1% respectively, and they were higher than 40% of the control group, but there was no statistically significant differences. Conclusions No matter the patients with intracerebral hemorrhage or cerebral infarction, the plasma sTM levels were significantly higher than the normal population; although TM 1418C/C genotype frequencies in patients with intracerebral hemorrhage and cerebral infarction in Chinese Han population were higher than normal population, they were not the susceptible genes of cerebrovascular disease.